Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05016310 · ClinicalTrials.gov registry record · NA

A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation

A NA study of Breast Cancer and Osteoporosis, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT05016310 is a NA study of Breast Cancer and Osteoporosis that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05016310, a NA study of Breast Cancer and Osteoporosis, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

This is a randomized study evaluating the effects of early intensive vitamin D supplementation compared to standard of care vitamin D supplementation on bone health over an 18 month period.

Interventions

  • DIETARY_SUPPLEMENT High Dose Vitamin D
  • DIETARY_SUPPLEMENT Standard of Care Vitamin D

Study Locations (1)

North Carolina

  • Levine Cancer Institute - Charlotte

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2021-09-16
Est. Completion 2024-08-15
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05016310

The ClinicalTrials.gov registry entry for NCT05016310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which High Dose Vitamin D is the first listed.

NCT05016310 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05016310 about?

NCT05016310 is a clinical study titled "A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation". This is a randomized study evaluating the effects of early intensive vitamin D supplementation compared to standard of care vitamin D supplementation on bone health over an 18 month period.

What is the current status of trial NCT05016310?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-09-16. Estimated completion is 2024-08-15.

What conditions does trial NCT05016310 study?

This clinical trial studies the following conditions: Breast Cancer, Osteoporosis, Breast.

What interventions are being tested in trial NCT05016310?

The interventions under investigation include: High Dose Vitamin D (DIETARY_SUPPLEMENT), Standard of Care Vitamin D (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05016310?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05016310 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.